Short answer · Medically reviewed summary · Last updated: 2026-04-07
TL;DR: IgA nephropathy (also known as Berger’s disease) is a chronic autoimmune kidney disorder that occurs when an antibody called immunoglobulin A (IgA) builds up in the kidneys, causing inflammation and damaging the filters that clean your blood. While it is a leading cause of kidney failure globally, the disease progression varies significantly between individuals, with many people maintaining stable kidney function for decades. What exactly happens in IgA nephropathy? IgA nephropathy affects the glomeruli, which are the tiny, delicate structures in your kidneys that filter waste and excess fluid from your blood.
TL;DR: IgA nephropathy (also known as Berger’s disease) is a chronic autoimmune kidney disorder that occurs when an antibody called immunoglobulin A (IgA) builds up in the kidneys, causing inflammation and damaging the filters that clean your blood. While it is a leading cause of kidney failure globally, the disease progression varies significantly between individuals, with many people maintaining stable kidney function for decades.
IgA nephropathy affects the glomeruli, which are the tiny, delicate structures in your kidneys that filter waste and excess fluid from your blood. In a healthy body, IgA is an antibody that helps fight off infections. In individuals with IgA nephropathy, abnormal IgA molecules clump together and deposit within the glomeruli. This accumulation triggers an inflammatory response, which can lead to scarring (glomerulosclerosis) and impair the kidney’s ability to function properly. Over time, this damage can lead to the leakage of protein or blood into the urine, and in some cases, a gradual decline in overall kidney function.
IgA nephropathy is considered the most common form of primary glomerulonephritis worldwide. While it can affect anyone, it is most frequently diagnosed in young adults, typically between the ages of 15 and 35. Research indicates that it occurs more often in men than in women, with a ratio of approximately 2:1. Geographically, there is a notable variation in prevalence, with higher rates observed in East Asian populations compared to those of European or African descent. Currently, 347 members of the DiseaseMaps.org community are living with this condition, sharing their unique experiences and management strategies.
Because IgA nephropathy often progresses slowly, many people may not experience symptoms in the early stages. When symptoms do appear, they can be subtle or sudden. Key clinical identifiers include:
Unlike some other forms of kidney disease that are caused by systemic autoimmune conditions like lupus or diabetes, IgA nephropathy is a "primary" glomerular disease, meaning the pathology is localized to the kidneys. A definitive diagnosis is typically made through a kidney biopsy, which allows pathologists to visualize the characteristic IgA deposits. Clinicians often use the MEST-C scoring system to classify the severity of the tissue damage, which helps in determining the most appropriate treatment plan for each patient.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the guidance of your physician or qualified health provider with any questions regarding a medical condition.